U.S. Rep. Brian Fitzpatrick (R-PA) applauded enactment Feb. 3 of a bipartisan bill he sponsored to expand Medicare coverage and remove barriers that prevent senior citizens from receiving life-saving infusion therapy at home.
The Joe Fiandra Access to Home Infusion Act of 2025, H.R. 4993, which Rep. Fitzpatrick sponsored in August 2025 alongside two original cosponsors, including U.S. Rep. Darren Soto (D-FL), became law with the president’s signature as part of the Consolidated Appropriations Act, 2026, H.R. 7148.
“Joe Fiandra’s legacy will permanently strengthen how Medicare delivers care — putting patients first and removing barriers that never should have existed,” Rep. Fitzpatrick said. “I… will continue working to ensure our healthcare system does what it exists to do — help people when they need it most.”
The congressman’s bill is named in honor of Joe Fiandra, a U.S. Army veteran and constituent of Pennsylvania’s First District who died in 2022 after battling amyloidosis.
The new law expands Medicare coverage by ensuring that external infusion pumps and certain non-self-administered drugs are covered as durable medical equipment (DME), removing obstacles to home-based treatment.
“Joe Fiandra served our nation with honor, loved his family fiercely, and faced his illness with courage,” said Rep. Fitzpatrick. “But his fight revealed a healthcare system that made an already difficult moment even harder. When I met with Joe’s wife, Helen, she asked for one thing — that no other family would have to endure the same struggle. Now, with the signing of this bill, that promise has become law.”
The legislation also strengthens transparency by requiring the U.S. Department of Health and Human Services to notify patients of applicable cost-sharing obligations for home infusion therapy compared to other care settings, according to a bill summary provided by the congressman’s staff.